Neuroendocrine Tumor Research Foundation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2020 | 4,650,373 | 4,020,651 | 629,722 | 46.0 | 18% |
| 2021 | 8,207,303 | 5,440,887 | 2,766,416 | 41.6 | 13% |
| 2022 | 3,075,371 | 3,490,037 | −414,666 | 48.2 | 22% |
| 2023 | 3,196,257 | 3,580,473 | −384,216 | 52.1 | 26% |
In its most recent public year (2023), this organization spent $384,216 more than it brought in. Its reserves stood at about 52.1 months of spending, up from 46 in 2020. Staff pay was 26% of spending. $12,684,349 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works